Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.37% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
Rating
3
Minimum Investment
₹100
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹189 Cr
Created on
1 Oct 2020
Fund Ranking
#15
/ 18 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
6 Month
16.2%
1 Year
24.4%
3 Year (CAGR)
18.8%
All Time (CAGR)
16.3%
Category Return
6 Month
21.7%
1 Year
18.3%
3 Year (CAGR)
20.2%
All Time (CAGR)
-
Asset Allocation
Equity
99.8%
Debt
0.2%
Other
0.1%
Top 5 Holdings
Top 5 Sectors
Apollo Hospitals Enterprise
5.71%
Aurobindo Pharma
2.70%
Cipla
4.84%
Dr. Reddy's Laboratories
4.44%
Ipca Laboratories
1.55%
Fund Information
Expense Ratio
1.10%
Exit Load
No Exit Load
Lock-In Period
No Lock-In
Managed By
Bhavesh Jain
Oct 2021 - Present
Amit Vora
Feb 2021 - Present
Manasi Jalgaonkar
April 2026 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
1.04
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
12.18
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
1.75
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.